Franklin Resources Inc. purchased a new stake in Travere Therapeutics, Inc. (NASDAQ:TVTX – Free Repo...
Guggenheim reissued a "buy" rating and set a $47.00 price target on shares of Travere Therapeutics i...
Travere Therapeutics (NASDAQ:TVTX – Get Free Report)‘s stock had its “buy” rating reissued by equiti...
Scotiabank analyst Greg Harrison lowered the firm’s price target on Travere Therapeutics (TVTX) to $...